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Summary
The aim of this study was to investigate whether a com-
bination of Doppler sonography (DS) and magnetic res-
onance venography (MRV) on 3T MRI increases speci-
ﬁcity for detection of chronic cerebrospinal venous in-
sufﬁciency (CCSVI) in 171 (113 relapsing-remitting, 47
secondary-progressive, 11 primary progressive) pa-
tients with multiple sclerosis (MS) and 79 age- and sex-
matched healthy controls (HCs). One hundred ten
(64.3%) MS patients and 30 (38%) HCs presented ≥2 ve-
nous hemodynamic CCSVI criteria (p<.0001). Both DS
and MRV showed relatively high speciﬁcity but lower
sensitivity for determining a CCSVI diagnosis in pa-
tients with MS vs HCs and between MS subgroups. In
MS patients this diagnostic speciﬁcity increased to
over 90% by combining internal jugular vein and verte-
bral vein abnormal DS and MRV ﬁndings, reﬂux in deep
cerebral veins and MRV ﬁndings of >1 collateral veins. 
This study suggests that a multimodal non-invasive ap-
proach (DS and MRV) increases the speciﬁcity for a di-
agnosis of CCSVI in patients with MS.
KEY WORDS: CCSVI, Doppler sonography, healthy controls, MR
venography, multiple sclerosis,  reproducibility, speciﬁcity
Introduction
Recently, a condition called chronic cerebrospinal ve-
nous insufﬁciency (CCSVI) was described in multiple
sclerosis (MS) patients with high frequency (1). It was
postulated that MS is associated with impaired brain ve-
nous drainage due to outﬂow obstruction in the extracra-
nial venous system, mostly related to anomalies in the in-
ternal jugular veins (IJVs) and azygos vein. Zamboni et
al. (1), using extracranial and transcranial Doppler
sonography (DS) of the neck, established ﬁve ultrasound
venous hemodynamic (VH) criteria that were able to dis-
tinguish MS patients from controls with 100% sensitivity
and speciﬁcity. Fulﬁllment of two or more VH criteria was
required to establish a diagnosis of CCSVI (1).
Several recently published studies utilizing DS (2-6),
magnetic resonance venography (MRV) (7-10) and
catheter venography (CV) (11,12) aimed to reproduce
these original ﬁndings. They gave variable results (as
regards CCSVI diagnosis) between MS patients and
controls, ranging from no difference to signiﬁcant differ-
ence, but they all showed a substantially lower preva-
lence of CCSVI than originally reported (1).
One of the main criticisms of the current non-invasive
CCSVI diagnostic approach is that DS is a highly oper-
ator-dependent imaging modality and not easy to blind
in a clinical setting. Also, the assessment of the second
VH criterion (reﬂux in deep cerebral veins) is controver-
sial because the direction of the blood ﬂow in veins con-
necting cortical with deep veins may vary considerably
as a consequence of the physiological inter-individual
variability of the cerebral venous anatomy (3). Moreover,
the reproducibility of individual VH criteria used for
CCSVI diagnosis is unknown at this time. 
In addition, there are no standard protocols for deﬁning
venous pathology using different imaging techniques,
which underlines the need for a multimodal approach to
the assessment of CCSVI in a larger cohort of MS pa-
tients and controls. If different imaging techniques are
found to show the same ﬁndings, this will not only estab-
lish the existence of a venous pathology that differentiates
between MS patients and healthy controls (HCs), but also
deﬁne its type. Moreover, the combination of different im-
aging techniques can inﬂuence the sensitivity and speci-
ﬁcity of a multimodal approach to the diagnosis of CCSVI.
Against this background, the purpose of our study was
to investigate the frequency of CCSVI in MS patients
and HCs using two non-invasive imaging techniques
(DS and MRV) and to explore whether these techniques
provide complementary information. We also aimed to
identify whether combining the ﬁndings from DS and
MRV can increase sensitivity and speciﬁcity for a diag-
nosis of CCSVI.
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Materials and methods
Subjects and clinical assessments
This case-control study was approved by the local insti-
tutional review board (IRB) and informed consent was
obtained from all subjects. The study included 171 con-
secutive MS patients and 79 age- and sex-matched HCs
who participated in our recently published Combined
Transcranial and Extracranial Venous Doppler (CTEVD)
study (5) and fulﬁlled the following inclusion and exclu-
sion criteria. Inclusion criteria for MS patients were: clin-
ically deﬁnite MS (13), with a relapsing-remitting (RR),
secondary-progressive (SP) or primary-progressive
(PP) disease course (14); age 18-65 years; Expanded
Disability Status Scale (EDSS) score of 0-6.5 (15), and
a diagnostic evaluation using DS and MRV. Exclusion
criteria were: a borderline ﬁnding on DS [borderline be-
ing deﬁned as a case in which one VH criterion is ful-
ﬁlled and another VH criterion is not determined for
technical reasons, making a CCSVI diagnosis impossi-
ble (5) – 7 cases were excluded on this basis]; pres-
ence of relapse and steroid treatment in the 30 days
preceding study entry; pre-existing medical conditions
known to be associated with neck pathology; history of
cerebral congenital vascular malformations, cerebral
venous thrombosis, central venous catheter in the IJV;
pregnancy; history of chronic obstructive pulmonary
disease; and arthritic neck (the subject may not be able
to lie ﬂat).
Doppler sonography
Participants underwent extra- and transcranial DS of the
head and neck performed using a color-coded DS scan-
ner (My Lab 25, Esaote-Biosound, Bologna, Italy)
equipped with a 2.5 and 7.5-10 MHz transducer. All sub-
jects were examined ﬁrst in the supine and then in the
sitting position (0° and 90° respectively) in accordance
with the previously reported CCSVI protocol (1,5). The
following 5 VH parameters indicative of CCSVI were in-
vestigated (Fig.s 1 and 2): 
1) Reﬂux/bidirectional ﬂow in the IJVs and/or in the ver-
tebral veins (VVs) in sitting and in supine positions (90°
and 0°), deﬁned as ﬂow directed toward the brain for a
duration of >0.88 s; 
2) Reﬂux/bidirectional ﬂow in the deep cerebral veins
(DCVs), deﬁned as reverse ﬂow for a duration of 0.5 s in
one of the intracranial veins; 
3) B-mode abnormalities or stenoses in IJVs, deﬁned as
cross-sectional areas (CSAs) of this vein ≤0.3 cm2, with
ﬂaps, webs, septa, etc., in the lumen of IJVs, considered
to be B-mode abnormalities signiﬁcantly disturbing cere-
bral venous outﬂow; 
4) Flow that is not Doppler-detectable in IJVs and/or
VVs despite multiple deep breaths; 
5) Reverted postural control of the main cerebral venous
outﬂow pathway determined by measuring the differ-
ence between the CSA of the IJVs in the supine and in
the upright positions. A subject was considered CCSVI-
positive if ≥2 VH criteria were fulﬁlled, as previously pro-
posed (1). The DS examination was performed by two
trained technologists who were blinded to each subject’s
characteristics, as previously described (5). We consid-
ered using DS for visualizing collaterals; however, be-
cause of technical limits we were not able to evaluate
these consistently. 
In order to test the reproducibility of the CCSVI criteria,
27 subjects (20 MS patients and 7 HCs) were examined
by two Doppler technologists who assessed all the sub-
jects twice over a one-week period in a blinded manner. 
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Figure 1 - Examples of positive Doppler sonography CCSVI criteria: (a) reﬂux/bidirectional ﬂow directed toward the brain for a duration
of >0.88 s in the supine position in the right internal jugular vein (RIJV); (b) reﬂux/bidirectional ﬂow in one of the deep cerebral veins
for a duration of 0.5 s; (c) septum intraluminal structural abnormality in the right internal jugular vein causing hemodynamic ﬂow abnor-
mality; (d) no visible ﬂow in the RIJV in the supine position; (e and f) reverted postural control of the RIJV with negative ∆CSA.
Magnetic resonance venography
All the subjects were examined on a 3T GE Signa Excite
HD 12.0 Twin Speed 8-channel scanner (General Elec-
tric, Milwaukee, WI). A multi-channel head and neck coil
manufactured by GE was used to acquire unenhanced
2D time-of-ﬂight (TOF) and enhanced 3D time-resolved
imaging of contrast kinetics (TRICKS) sequences, as
previously described (9). The parameters used for TOF
were: TR/TE 17/4.3 ms (repetition/echo time), ﬂip angle
of 70 degrees, 1.5 mm slice thickness, ﬁeld of view
(FOV)=220 mm, acquisition matrix 320/192, phase FOV
75%, for an in-plane resolution (IPR) of 0.7 mm x 1.1 mm,
and acquisition in axial scan plane. The parameters used
for TRICKS were: TR/TE 4.2/1.6 ms, ﬂip angle of 30 de-
grees, 2 mm slice thickness, FOV=340 mm, acquisition
matrix 320/192, phase FOV 75%, IPR=1.1 mm x 1.8 mm,
and acquisition in coronal scan plane. Intravenous
gadolinium contrast (Omniscan®, GE Healthcare,
Princeton, NJ) was injected at a rate of 2ml/s using a
pressure injector followed by a 20 ml saline ﬂush. The
total volume of contrast was 20 ml. After acquisition of a
12-second mask (pre-contrast phase), the scanning of
subsequent phases began simultaneously with the intra-
venous injection. The scan protocol consisted of 18
phases of acquisition, each of 5 seconds’ duration. 
Both MS patients and HCs underwent unenhanced TOF
but TRICKS was performed only in the MS patients. The
local IRB did not recommend participation by HCs in the
contrast portion of the MRV study.
Two independent neuroradiologists (DH and KD) exam-
ined all MRI scans. Both readers had access only to the
angiographic series but not to the structural MR images,
and were blinded to the demographics (except date of
birth) and clinical information of all the study subjects.
Scan-rescan MRV reproducibility data were previously
reported (9). 
The ﬂow morphology of the IJVs was assessed on axial
source TOF images, as well as on axial reconstructed
TRICKS images, as previously described (9). We evalu-
ated IJV ﬂow on an ordinal scale ranging from absent
(no visible ﬂow) to ellipsoidal (patent lumen) and deﬁned
ﬁve qualitative ﬂow categories: absent, pinpoint, ﬂat-
tened, crescentic and ellipsoidal. Only absent or pin-
point ﬂow of the IJVs was considered to be abnormal
ﬂow (Fig. 3, over). Flow of the VVs was classiﬁed as ab-
sent/present (Fig. 2). 
In this study we also assessed the prominence of the
other more important veins in the neck visible on MRV,
as previously described (9). These included the external
jugular veins (EJVs), anterior jugular veins, facial veins,
thyroid veins and deep cervical veins (Fig. 4, over).
Veins were deemed prominent when their diameter was
greater than 5 mm, or greater than 7 mm when consid-
ering the inferior segment of the EJVs (in accordance
with the protocol used previously) (9,16). We evaluated
the presence and number of collateral veins.
Multimodal imaging comparisons
In order to compare abnormal DS IJV and MRV IJV ﬁnd-
ings we considered only those VH criteria that are relat-
ed to IJV pathology (positive VH criteria 1, 3, 4 and/or 5).
Accordingly, the presence of at least one of the follow-
ing IJV anomalies was taken to constitute an abnormal
IJV exam: for DS, the presence of reﬂux/bidirectional
ﬂow in both sitting and supine positions, the presence of
B-mode abnormalities (web, flap, membrane, mal-
CCSVI and diagnostic techniques
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Figure 2 - Examples of vertebral vein (VV) ﬂow abnormalities on Doppler sonography and MR venography: (a) no visible ﬂow on axial
2D time-of-ﬂight and (b) enhanced axial 3D time resolved imaging of contrast kinetics in both VVs; (c) no visible ﬂow in the left VV in
upright position on Doppler sonography.
K. Dolic et al.
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Figure 4 - Examples of prominent extracranial neck veins (collaterals) on MR venography: (a) prominent anterior jugular veins (both),
(b) prominent left facial vein and (c) prominent deep cervical veins on axial 2D time-of-ﬂight, (d) prominent left external jugular vein
on enhanced 3D time resolved imaging of contrast kinetics sequence.
Figure 3 - Examples of abnormal internal jugular vein (IJV) ﬂow morphology on MR venography and Doppler sonography: (a) absent
ﬂow in left IJV on axial 2D time-of-ﬂight and (b and c) on enhanced 3D time resolved imaging of contrast kinetics, and (d) no ﬂow in
left IJV on Doppler sonography; (e) pinpoint ﬂow morphology in both IJVs on axial 2D time-of-ﬂight and (f and g) on enhanced 3D ti-
me resolved imaging of contrast kinetics images; (h) Doppler sonography shows reduction of lumen and ﬂow in the left IJV and (i)
right IJV.
formed valve, septum), the presence of stenoses, the
absence of detectable ﬂow, and a negative cross-sec-
tional area (∆CSA); for MRV, absent or pinpoint ﬂow.
Similar classiﬁcation criteria were developed to compare
abnormal DS VV and MRV VV ﬁndings. Positive VH cri-
teria 1 and/or 4 (reﬂux/bidirectional ﬂow and absence of
detectable ﬂow) were taken to constitute abnormal DS
exams, while absence of ﬂow denoted abnormal MRV
(Fig. 2).
We also combined abnormal DS IJV and VV and abnor-
mal MRV IJV and VV ﬁndings with reﬂux in the DCVs
(positive VH criterion 2) and with the number of collater-
al veins to create the best combination of various imag-
ing criteria that could potentially increase the speciﬁcity
and sensitivity of the venous pathology ﬁndings in MS
patients vs HCs. 
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS, version 17.0). For
statistics between the groups, the t-test, chi-square test
and Mann-Whitney rank sum U-test were used. Preva-
lence rates for each of the ﬁve criteria, as well as for dif-
ferent CCSVI status groups, were calculated using the
chi-square test. Reproducibility was calculated using
Cohen’s Kappa and inter-class correlation (ICC) tests.
MS patients were further divided into two groups: MS
non-progressive (RR) and MS progressive patients (SP
and PP). Sensitivity and speciﬁcity were determined for
CCSVI diagnosis, individual DS VH criteria, MRV ﬂow
ﬁndings and presence and number of collateral veins.
Values were calculated separately for MS patients vs
HCs, as well as progressive vs non-progressive MS pa-
tients. We determined the sensitivity and speciﬁcity be-
tween both HCs and MS patients, as well as between
MS subgroups using crosstabs and direct computation
from 2 x 2 contingency tables. 
In order to avoid too many spurious ﬁndings due to mul-
tiple comparisons, a nominal p-value <.01 was consid-
ered as signiﬁcant using two-tailed tests. 
Results
Demographic and clinical characteristics
Table 1 shows the demographic, clinical and treatment
characteristics of the study groups. The mean age of the
MS patients was 44.5 years (SD 10.8), mean disease du-
ration 12.7 years (SD 9.6) and median EDSS score 2.5.
One hundred nineteen (69.6%) MS patients were females.
HCs were age- and sex-matched to the MS patients. As
expected, patients with progressive MS had signiﬁcantly
higher age and EDSS scores, and a longer disease dura-
tion than non-progressive MS patients (all p<.001). 
CCSVI criteria: reproducibility results
Table 2 (over) shows the scan-rescan reproducibility da-
ta for CCSVI status and individual VH criteria. Positive
CCSVI diagnostic assessment (≥2 fulﬁlled VH criteria)
showed modest inter-operator agreement (Kappa 0.64).
Assessments of individual VH criteria 2 and 5 showed
low inter-operator agreement (Kappa 0.1 and 0.2, re-
spectively). There was high inter-operator correlation
(ICC, 0.75) for assessment of the number of VH criteria.
The assessment of individual IJV and VV VH criteria al-
so showed modest to high agreement.
CCSVI prevalence rates in the study groups
Table 3 (over) shows the prevalence rates of global and
individual VH criteria indicative of CCSVI between MS
patients and HCs. The prevalence of CCSVI was 64.3%
for MS and 38% for HCs (p<.001), 58.4% for non-pro-
gressive MS patients and 75.9% for progressive MS pa-
tients (p=.017). The prevalence of VH criterion 3 was
highest in progressive MS patients (79.3%), followed by
non-progressive MS patients (63.7%) and HCs (45.6%)
(p<0.001). At least one positive criterion was found in
87.1% of MS patients and 72.7% of HCs.
The ≥1 DS VH IJV criteria prevalence rates were 78.2% for
MS and 54.4% for HCs (p<.001), 74.3% for non progres-
CCSVI and diagnostic techniques
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Table 1 - Demographic and clinical characteristics in multiple sclerosis patients and healthy controls.
MS HCs p NPR-MS PR-MS p
(n=171) (n=79) (n=113) (n=58)
Female gender, n (%) 119 (69.6) 48 (60.8) NS 83 (73.5) 36 (62.1) NS
Age in years, mean (SD) 44.5 (10.8) 43.9 (14.3) NS 41.6 (10.3) 50.4 (9.3) <.001
Age at onset, mean (SD) 31.6 (10.1) – – 32.2 (9.9) 30.6 (10.7) NS
Disease duration, mean (SD) 12.7 (9.6) – – 9.7 (8.2) 18.8 (9.6) <.001
Disease course, n (%)
RR 113 (66.1) – – 113 (100) –
SP 47 (27.5) – – – 47 (81) –
PP 11 (6.4) – – – 11(19) –
EDSS, mean (SD) 3.4 (2.3) – – 2.3 (1.5) 5.9 (1.7) <.001
median 2.5 2.0 6.0
Abbreviations: MS=multiple sclerosis; HCs=healthy controls; RR=relapsing-remitting; PP=primary progressive; SP=secondary pro-
gressive; EDSS=Expanded Disability Status Scale; NS=not signiﬁcant; NPR=non-progressive; PR=progressive.
Of the 171 MS patients, 121 (70.7%) were on disease-modifying therapy. These included 34 patients on glatiramer acetate, 33 on interferon-beta 1a I.M.,
22 on natalizumab, 20 on interferon-beta 1a S.C. and 12 on combination therapy. The differences between the study groups were tested using the chi-
square test, Student’s t-test and Mann-Whitney rank sum test.
sive MS patients, and 84.5% for progressive MS patients
(p=.06). There was no signiﬁcant difference in the preva-
lence of ≥1 DS VH VV criteria between the study groups. 
MRV ﬁndings in the internal jugular and vertebral
veins
Table 4 shows MRV ﬁndings of IJV ﬂow morphology in
MS patients and HCs on TOF and TRICKS. No signiﬁcant
differences were found on the IJV ﬂow morphology scale
between MS patients and HCs (p=.192), but there were
signiﬁcant differences between MS progressive and MS
non-progressive patients on TOF (p=.01) and TRICKS
(p=.003). IJV ﬂow abnormalities were detected in 32.2%
of MS patients and 24.1% of HCs on TOF (Table 5). 
Absent VV ﬂow was found in 17.7% of HCs and in
13.5% of MS patients on TOF (p=.242); however, absent
VV ﬂow was found more in progressive MS patients
K. Dolic et al.
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Table 2 - Intra- and inter-rater reproducibility of CCSVI criteria on Doppler sonography between two trained operators in 20
MS patients and 7 healthy controls.
Categoric variables
Operator 1 Operator 2 Operator 1 vs operator 2 
Agreement (%) Kappa Agreement (%) Kappa Agreement (%) Kappa 
≥2 VH criteria 82.6 0.620 66.7 0.341 83.3 0.640
≥1 VH criteria 100 1 85.7 0.577 88.9 0.600
≥1 VH IJV criteria 95.6 0.893 63.6 0.170 78.9 0.513
≥1 VH VV criteria 95.6 0.862 95.2 0.889 88.9 0.753
VH criterion 1 100 1 100 1 100 N/A
VH criterion 2 86.95 0.732 81 0.538 50 0.110
VH criterion 3 100 0.911 66.7 0.310 77.8 0.538
VH criterion 4 91.3 0.744 85.7 0.690 83.3 0.649
VH criterion 5 78.3 0.493 76.2 0.146 77.8 0.200
Numeric variables ICC ICC ICC
Number VH criteria – 0.740 – 0.562 – 0.745
Number VH IJV criteria – 0.803 – 0.447 – 0.541
Number VH VV criteria – 0.867 – 0.894 – 0.764
Abbreviations: ICC=inter-class correlation; VH=venous hemodynamic; IJV=internal jugular vein; VV=vertebral vein.
Intra- and inter-rater reproducibility was calculated using Cohen’s Kappa and inter-class correlation tests.
Table 3 - Prevalence, sensitivity and speciﬁcity of global and individual venous hemodynamic criteria in MS patients and
healthy controls.
HCs MS pa Speciﬁcity NPR-MS PR-MS pb Speciﬁcity
(n=79) (n=171) (n=113) (n=58)
VH criterion 6 (7.6) 47 (27.5) < .001 92.4% 32 (28.3) 15 (25.9) .44 71.7%
1, n (%)
VH criterion 27 (34.2) 89 (52) .006 65.8% 56 (49.6) 33 (56.9) .23 50.1%
2, n (%)
VH criterion 36 (45.6) 118 (69) < .001 54.4% 72 (63.7) 46 (79.3) .026 36.3%
3, n (%)
VH criterion 15 (19) 37 (21.6) .382 81% 21 (18.6) 16 (27.6) .124 81.4%
4, n (%)
VH criterion 8 (10.1) 31 (18.1) .073 89.9% 15 (13.3) 16 (27.6) .02 86.7%
5, n (%)
≥2 VH 30 (38) 110 (64.3) < .001 86.8% 66 (58.4) 44 (75.9) .017 61.1%
criteria, n (%)
≥1 VH 57 (72.7) 149 (87.1) .004 27.8% 94 (83.2) 55 (94.8) .023 16.8%
criteria, n (%)
≥1 VH IJV 43 (54.4) 133 (87.1) < .001 45.6% 84 (74.3) 49 (84.5) .06 25.7%
criteria, n (%)
≥1 VH VV 12 (15.2) 24 (14.1) .481 84.8% 16 (14.2) 8 (13.8) .592 85.8%
criteria, n (%)  
Abbreviations: MS=multiple sclerosis patients; HCs=healthy controls; NPR=non-progressive; PR=progressive; VH=venous hemody-
namic.
a p-value for chi-square test represents comparison between HCs and MS; b p-value for chi-square test represents comparison between non-progressive
and progressive MS patients. The sensitivity of MS vs HCs and NPR-MS vs PR-MS is represented in italics.
(24.1%, p=.004 on TOF; and 12.1%, p=.044 on
TRICKS) than in non-progressive patients (Table 5). 
Collateral veins: MRV ﬁndings
Table 5 shows the presence and number of collateral veins
in MS patients and HCs. No signiﬁcant differences were
found in the presence of collaterals between MS patients
(91.8%) and HCs (89.8%) on TOF, or between MS non-
progressive (91.2%) and progressive patients (93.1%).
The TRICKS sequence also showed no difference in the
presence of collaterals between MS subgroups. There
was a trend toward a higher mean number of collateral
veins in MS patients compared to HCs on TOF (2.1 vs 1.8,
p=.05). There was also a trend toward a higher number of
collaterals on the right side in the MS patients than in the
HCs (p=.037). No differences in number of collateral veins
were found between progressive and non-progressive MS
patients on TOF (p=.679) or TRICKS (p=.886). 
Multimodal imaging ﬁndings 
The presence of ≥2 positive DS VH criteria indicative of
CCSVI showed acceptable sensitivity (64.3%) and high
speciﬁcity (86.8%) for MS vs HCs, as well as between
MS subgroups (sensitivity 75.9% and speciﬁcity 61.1%)
(Table 3). Individual DS VH criteria 1 (92.4%), 4 (81%)
and 5 (89.9%) and ≥1 DS VH VV criteria (84.8%)
showed the highest speciﬁcity for distinguishing MS vs
HCs, as well as progressive vs non-progressive MS pa-
CCSVI and diagnostic techniques
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Table 4 - Flow morphology of internal jugular veins in multiple sclerosis patients and healthy controls on 2D time-of-ﬂight
venography and 3D time resolved imaging of contrast kinetics.
TOF TOF TOF TOF TRICKS TRICKS
Morphology Score HCs MS NPR-MS PR-MS NPR-MS PR-MS
(n=79) (n=171) (n=113) (n=58) (n=113) (n=58)
Absent, n (%) 7 (8.9) 24 (14) 11 (9.7) 13 (22.4) 5 (4.4) 6 (10.7)
Pinpoint, n (%) 15 (19) 30 (17.5) 16 (14.2) 14 (24.1) 18 (15.9) 19 (33.9)
Flattened, n (%) 24 (30.4) 54 (31.6) 38 (33.6) 16 (27.6) 39 (34.5) 16 (28.6)
Crescentic, n (%) 3 (3.8) 2 (1.2) 2 (1.8) 0 (0) 2 (1.8) 2 (3.4)
Ellipsoidal, n (%) 30 (38) 61 (35.7) 46 (40.7) 15 (25.9) 45 (39.8) 15 (26.8)
p=.192 p=.01 p=.003
Abbreviations: MS=multiple sclerosis patients; HCs=healthy controls; NPR=non-progressive; PR=progressive; TOF=time-of-ﬂight
venography; TRICKS=time resolved imaging of contrast kinetics; n=number.
The differences on the ordinal morphological ﬂow scale between the study groups were evaluated using the Mann-Whitney rank sum test.
Table 5 - Prevalence, sensitivity and speciﬁcity of extracranial vein ﬂow abnormality in multiple sclerosis patients and healthy
controls on 2D time-of-ﬂight venography and 3D time resolved imaging of contrast kinetics.
TOF TOF p Speci- TOF TOF p Speci- TRICKS TRICKS p Speci-
ﬁcity ﬁcity ﬁcity
HCs MS NPR-MS PR-MS NPR-MS PR-MS
(n=79) (n=171) (n=113) (n=58) (n=113) (n=58)
Abnormal IJV 19 (24.1) 55 (32.2) .123 75.9% 29 (25.7) 26 (44.8) .009 74.3% 23 (22.1) 25 (44.6) .003 77.9%
ﬂow, n (%)
Absent VV 14 (17.7) 23 (13.5) .242 82.3% 9 (8) 14 (24.1) .004 92% 4 (3.8) 7 (12.1) .044 96.2%
ﬂow, n (%)
Presence of 72 (91.1) 156 (91.2) .576 8.9% 103 (91.2) 54 (93.1) .602 8.8% 92 (88.5) 50 (89.3) .55 11.5%
collaterals, n (%)
1 collateral 24 (30.4) 40 (23.4) 69.6% 27 (23.9) 13 (22.4) 76.1% 24 (21.2) 15 (25.9) 73.9%
2 collaterals 30 (38) 59 (34.5) 62% 40 (35.4) 19 (32.8) 32.8% 33 (29.2) 15 (25.9) 64.1%
3 collaterals 12 (15.2) 37 (21.6) 84.8% 19 (16.8) 18 (31) 83.2% 19 (16.8) 16 (27.6) 79.3%
≥4 collaterals 5 (6.3) 21 (12.3) 93.7% 17 (15) 4 (6.9) 85% 16 (14.2) 4 (6.9) 82.6%
Number of
collaterals, 1.8 (1.1) 2.1 (1.2) .05 2.1 (1.3) 2.1 (1.2) .679 2.1 (1.4) 2.1 (1.3) .783
mean (SD)
Abbreviations: MS=multiple sclerosis patients; HCs=healthy controls; NPR=non-progressive; PR=progressive; TOF=time-of-ﬂight
venography; TRICKS=time resolved imaging of contrast kinetics; n=number.
The frequency differences between the study groups were tested using the chi-square test, whereas the number of collaterals was tested using the Mann-
Whitney rank sum test. Sensitivity of MS vs HCs and NPR-MS vs PR-MS is represented in italics.
tients. When the presence of ≥1 DS VH criteria was
used to assess venous pathology in MS vs HCs, there
emerged a high sensitivity for patients with MS (87.1%),
but the speciﬁcity was low (27.8%). This pattern was al-
so seen for progressive vs non-progressive MS patients
(sensitivity of 94.8% vs speciﬁcity of 16.8%). 
Although we did not ﬁnd signiﬁcant differences between
MS patients and HCs regarding abnormal MRV IJV ﬂow,
MRV did show high diagnostic speciﬁcity in MS patients
vs HCs on TOF (75.9%), as well as for distinguishing be-
tween progressive vs non-progressive MS patients on
TOF (74.3%) and TRICKS (77.9%). The presence of ab-
normal MRV VV ﬂow and the presence of collaterals
showed even higher speciﬁcity. The presence of ≥4 col-
lateral veins showed the highest diagnostic speciﬁcity
for MS patients (Table 5).
When we combined ≥1 DS VH VV criteria and abnormal
MRV VV ﬂow, we found a high diagnostic speciﬁcity
(92.4%) for MS patients vs HCs and for progressive vs
non-progressive MS patients (92%) (Table 6). Speciﬁci-
ty increased substantially when ≥1 DS VH IJV criteria
were combined with abnormal MRV IJV ﬂow criteria
(84.8% for MS vs HCs and 76.1% for progressive vs
non-progressive MS patients). 
The combination of abnormal MRV IJV ﬂow and DS VH
criterion 2 and ≥1 collaterals also yielded high speciﬁci-
ty for MS vs HCs (91.1%) and between MS subgroups
(83.6%), while combining ≥1 DS VH VV criteria and DS
VH criterion 2 and >1 collaterals gave even higher
speciﬁcity. The highest sensitivity (38.6%) for MS was
achieved by combining ≥1 DS VH IJV criteria and DS
VH criterion 2 and >1 collaterals (Table 6).
Discussion
This study investigated the sensitivity and speciﬁcity of
two non-invasive imaging techniques for the screening
of CCSVI in a large cohort of MS patients and HCs. We
found that ≥2 DS VH criteria showed high speciﬁcity, but
lower sensitivity, for determining a CCSVI diagnosis in
MS patients vs HCs and between MS subgroups. Indi-
vidual VH criteria 1, 4 and 5 showed high speciﬁcity for
distinguishing MS patients from HCs, but also lower
sensitivity. Although MRV did not show signiﬁcant differ-
ences on the ﬂow morphology scale between MS pa-
tients and HCs, it showed high speciﬁcity, but low sensi-
tivity, for distinguishing MS patients from HCs and pro-
gressive from non-progressive MS patients, based on
abnormal venous ﬂow. Nevertheless, MRV was comple-
mentary to DS in differentiating progressive from non-
progressive MS patients and in showing collaterals. Ab-
normal VV ﬁndings on DS and MRV showed very high
speciﬁcity for distinguishing MS patients vs HCs, as did
the presence of >1 collaterals on MRV, but again with
low sensitivity. Most importantly, diagnostic speciﬁcity
for MS patients increased to over 90% when we com-
bined IJV and VV abnormal DS and MRV ﬁndings with
positive VH criterion 2 and >1 collaterals on MRV. 
From a diagnostic standpoint, one of the main criticisms
of the DS criteria for CCSVI diagnosis is that these cri-
teria are operator-dependent (5,17,18). A previous study
showed that reproducibility of the CCSVI diagnostic cri-
teria depends on training level (17). We recently showed
modest to high intrarater agreement for establishing a
CCSVI diagnosis (5). In order to provide more evidence
for reproducibility of individual IJV/VV VH criteria, 20 MS
patients and 7 HCs were examined one week apart by
two blinded and previously trained Doppler technolo-
gists. We showed modest to high inter-rater agreement
for determining a CCSVI diagnosis, as well as for the ful-
ﬁllment of ≥1 individual DS IJV/VV VH criteria. Of the in-
dividual DS VH criteria, the most reproducible were cri-
teria 1, 3 and 4, while criteria 2 and 5 were less repro-
ducible. These ﬁndings suggest that global DS VH crite-
ria for determining CCSVI diagnosis are more repro-
ducible than individual VH criteria. Therefore, although
the DS CCSVI protocol requires appropriate training be-
fore it can be applied (5,17,19), the inter-rater repro-
ducibility data from the present study support its use in
multi-center studies and for possible diagnostic purposes. 
In the present study, 64.3% of MS patients and 38% of
HCs presented with ≥2 VH criteria and were classiﬁed
as having CCSVI. CCSVI prevalence in MS patients and
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Table 6 - Prevalence, sensitivity and speciﬁcity of multimodal venous hemodynamic criteria in MS patients and healthy con-
trols that showed the highest speciﬁcity values.
Mutimodal combination of criteria Sensitivity Speciﬁcity Sensitivity Speciﬁcity
MS vs HCs MS vs HCs NPR-MS vs PR-MS NPR-MS vs PR-MS
≥1 DS VH IJV criteria and
abnormal MRV IJV ﬂow 28.7% 84.8% 37.9% 76.1%
≥1 DS VH VV criteria and
abnormal MRV VV ﬂow 29% 92.4% 24.1% 92%
≥1 DS VH IJV criteria and DS VH
criterion 2 and > 1 collaterals 38.6% 81% 43.1% 63.7%
Abnormal MRV IJV ﬂow and DS VH
criterion 2 and > 1 collaterals 16.4% 91.1% 16.4% 83.6%
≥1 DS VH VV criteria and DS VH
criterion 2 and > 1 collaterals 6.4% 94.9% 5.2% 92.9%
Abnormal MRV VV ﬂow and DS
VH criterion 2 and > 1 collaterals 5.2% 94.8% 12.1% 99.1%
Abbreviations: MS=multiple sclerosis patients; HCs=healthy controls; NPR=non-progressive; PR=progressive; VH=venous hemody-
namic.
HCs was somewhat higher than reported in our recent-
ly published CTEVD study (5), but substantially lower
than originally reported (for MS patients) (1). One of the
exclusion criteria in the present study was a borderline
ﬁnding on DS, which could have contributed to higher
prevalence in the study groups. The main reason for ex-
clusion of the 7 cases that were originally part of the
CTEVD study (5) and presented with a borderline DS
exam was comparison with MRV (we did not have a bor-
derline category for MRV). The most common VH crite-
rion in both MS patients and HCs was VH criterion 3, as
in our previous study (5), which represents proximal IJV
stenosis due to intraluminal abnormalities (9,10). This is
also in line with our previous work where we found that
the most frequent venous abnormalities in the IJVs, in-
dicative of CCSVI, are of intraluminal origin (19). In ad-
dition, we found more MS patients fulﬁlling ≥1 DS IJV
VH criteria, compared with HCs. This ﬁnding suggests
that most of the venous abnormalities are localized at
the IJV level. Without recourse to invasive CV exams, it
is difﬁcult to establish how much azygos vein pathology
contributes to the CCSVI diagnosis (1,20). However, our
VH ﬁndings in the VVs did not show a difference be-
tween the study groups.
Sensitivity and speciﬁcity data for diagnosing CCSVI with
DS were substantially lower compared to the initial
CCSVI study (1), but in line with our previous study (5).
Although DS showed lower sensitivity, the speciﬁcity for
distinguishing MS patients vs HCs was rather high when
considering ≥2 positive VH criteria, and individual VH cri-
teria 1, 4 and 5. The most common VH criterion both in
MS patients and in HCs, as well as in the MS subgroups,
was VH criterion 3, but it showed the lowest speciﬁcity in
all groups. We did not use Quality Doppler Proﬁle tech-
nology for detection of DS VH criterion 2 due to the inabil-
ity of our DS scanner. This could have inﬂuenced the sen-
sitivity and speciﬁcity results in relation to DS VH criteri-
on 2 found in the present study. Speciﬁcity and sensitivi-
ty for differentiating progressive vs non-progressive MS
patients based on individual DS VH criteria and CCSVI
diagnosis were lower than the values for MS vs HCs.
In contrast to DS, MRV showed abnormal IJV ﬂow mor-
phology in only 32.2% of the MS subjects and 24.1% of
the HCs, which is in line with several recently published
small-scale MRV venous ﬂow studies (7-9). In our previ-
ous study (9), we investigated the potential value of
MRV for assessing morphology of the extracranial ve-
nous system in 57 patients with MS and 21 HCs, and
found no difference between the study groups. Wattjes
et al., in a group of 20 patients with deﬁnite MS and 20
age- and sex-matched HCs, analyzed intracranial and
extracranial neck veins for stenosis/occlusion and alter-
native venous drainage patterns, and found no differ-
ence in the prevalence of venous stenoses between the
MS patients and HCs (8). In another study, IJV outﬂow
and reﬂux were studied in 21 MS patients and 20 HCs,
and no differences between the study groups were
found (7). Similarly, in our recent work that included 150
MS patients and 63 age- and sex-matched HCs, we did
not ﬁnd signiﬁcant differences on the morphological ﬂow
MRV scale between MS patients and HCs (19). Despite
the fact that head and neck veins are clearly shown us-
ing MRV, this technique does not have the resolution to
visualize intraluminal abnormalities and it lacks dy-
namism in real time. These are the main limitations
when comparing MRV with DS, as discussed in a recent
multimodal diagnostic study (10). Given that intraluminal
abnormalities are the most frequent type of venous ab-
normality in the CCSVI criteria (1,5,6,10,19), this may
further explain the discrepant results between DS (1,10)
and MRV studies. However, MRV can detect the extra-
luminal abnormalities represented by stenoses, as
shown in our recent work (19). 
In the present study, signiﬁcantly more progressive than
non-progressive MS patients presented with MRV ﬂow
morphology abnormalities on both TOF and TRICKS.
There also emerged a trend toward higher CCSVI preva-
lence on DS in progressive vs non-progressive MS pa-
tients, and toward higher prevalence of ≥1 DS VH IJV cri-
teria in progressive MS patients. These ﬁndings suggest
that progressive MS patients present with more MRV and
DS venous abnormalities in their IJVs than non-progres-
sive MS patients. This is also in line with a recent study
that found signiﬁcantly more extraluminal DS abnormali-
ties and more ﬂow abnormalities on MRV in progressive
than in non-progressive MS patients (19). Further studies
need to investigate whether age (progressive MS pa-
tients are generally older) or disease duration can inﬂu-
ence the prevalence of IJV abnormalities in MS patients,
as has been recently shown in elderly HCs (21,22). 
Regarding sensitivity and speciﬁcity, MRV data showed
high speciﬁcity for diagnosis of MS based on MRV ab-
normal IJV ﬂow on TOF, as well between MS subgroups
on TOF and TRICKS sequences. These ﬁndings sug-
gest that MRV should be used as a complementary non-
invasive screening tool to DS for diagnosing CCSVI, de-
spite its lower sensitivity. 
Zamboni et al. (23) proposed that extracranial venous
collateral circulation in MS patients is a compensatory
mechanism for impaired venous outﬂow, because it by-
passes blocked veins and thereby reduces resistance to
drainage. The present study established that MRV is
more accurate than DS for obtaining a global view of the
extracranial venous system. Using the TOF technique or
administering intravenous contrast in the cubital vein,
the global intra- and extracranial venous system can be
shown non-invasively, which is not possible with CV (in-
vasive technique) or DS (technical inability to follow the
complete course of the collateral vein) (8,9). On MRV,
we found that MS subjects, compared with HCs, showed
a trend toward more collaterals, but collaterals were al-
so very frequent in subjects with normal DS or MRV
ﬁndings. In addition, we did not ﬁnd a signiﬁcant differ-
ence in the number of collaterals between non-progres-
sive and progressive MS patients, either on the TOF or
the TRICKS images, which is in line with our recent
study (19). However, we found high speciﬁcity for distin-
guishing MS vs HCs and MS subgroups based on the
number of collaterals (especially >1 collaterals) on TOF
and TRICKS. Therefore, collateral veins probably repre-
sent physiological variations of the venous system that
may play a compensatory role when there are more ve-
nous extracranial stenoses present. 
One of the main study aims was to investigate whether
the sensitivity and speciﬁcity for MS would increase by
combining the DS and MRV IJV and VV abnormal ﬁnd-
ings with the presence of DS VH criterion 2 (DCV reﬂux)
and number of collaterals. Overall, our ﬁndings show
that combination of all 4 criteria (DS VH IJV, MRV IJV,
DS VH criterion 2 and number of collaterals) yielded
CCSVI and diagnostic techniques
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speciﬁcity of over 85% while the sensitivity still remained
between 20% and 30%. On the other hand, when we
used a different combination of 4 criteria (DS VH VV,
MRV VV, DS VH criterion 2 and number of collaterals)
speciﬁcity was over 90% but the sensitivity dropped to
less than 10%. Low sensitivity indicates that only a sub-
population of MS patients presents with a severe ve-
nous pathology. In addition, more quantitative measures
for deﬁnition of venous abnormalities, such as blood
ﬂow velocity and blood volume ﬂow on DS as well as on
phase-contrast MRV could probably increase the sensi-
tivity for assessing the degree of venous outﬂow ob-
struction in the IJVs and VVs. Future studies should al-
so investigate whether impairment on cerebrospinal ﬂu-
id hemodynamic MRI measures may increase the sen-
sitivity and speciﬁcity of the CCSVI criteria (24). 
In conclusion, despite the limitations in comparing differ-
ent imaging techniques and the use of different imaging
criteria, this study suggests that conventional MRV has
complementary value for detection of extracranial ve-
nous anomalies, although DS is more sensitive in identi-
fying venous abnormalities related to CCSVI in MS pa-
tients vs HCs. The study showed that use of a multi-
modal approach for determining the degree of extracra-
nial venous impairment may substantially increase speci-
ﬁcity in distinguishing MS patients from HCs, as well as
between progressive vs non-progressive MS subgroups. 
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